Feature Channels:

AIDS and HIV

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

HIV, AIDS, Cytomegalovirus, Mother To Child Transmission, Infant, CMV, brain damage infants, Fetal Growth, Liver Damage, lung damage, spleen damage, Hearing Loss, HIV Positive Women

HIV-Positive Women with Cytomegalovirus Likelier to Pass Virus That Causes AIDS to Infant

Cytomegalovirus.jpg

HIV-positive women with CMV in their urine at the time of labor and delivery are more than five times likelier than HIV-positive women without CMV to transmit HIV to their infants. The research also found that they are nearly 30 times likelier to transmit CMV to their infants.

Medicine

Channels:

Dr. Crotty , La Jolla Institute , HIV, Hiv Vaccine, La Jolla Institute for Allergy and Immunology

San Diego Team Tests Best Delivery Mode for Potential HIV Vaccine

HIVspikes1jr.jpg

For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching closer. Their latest study, published in the current issue of Immunity, demonstrates that optimizing the mode and timing of vaccine delivery is crucial to inducing a protective immune response in a preclinical model.

Medicine

Channels:

DNA-Cutting Enzyme, Drug for High-Risk Leukemias, Infant Sun Protection, and More in the Children's Health News Source

Click here for the latest research and features on Children's Health.

Medicine

Channels:

Teaching Transgender Respect, Methamphetamine Use Disorder Trial, Rx Drug Cost, and More in the Healthcare News Source

The latest research, features and announcements in healthcare in the Healthcare News Source

Medicine

Channels:

HIV, MSM, viral suppression, seroadaptation

Knowing HIV Levels Are ‘Undetectable’ May Affect Sexual Behavior

Understanding and responding to behavioral trends in groups that are at high risk for HIV infection is critical to the development of effective strategies that decrease HIV incidence and improve access to care. New research based on data from the Centers for Disease Control and Prevention’s National HIV Behavioral Surveillance (NHBS) system are presented in a special supplement to JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Wolters Kluwer.

Medicine

Channels:

HIV, AZT, AIDS, Antiretrovirals

Plant Compound More Powerful Than AZT Against HIV

willowleavedplant.jpg

A plant found throughout Southeast Asia traditionally used to treat arthritis and rheumatism contains a potent anti-HIV compound more powerful than the drug AZT, according to a new paper published in the Journal of Natural Compounds.

Medicine

Channels:

Amid Russia Conflict and Drug Epidemic, SUNY Downstate Researchers Battle HIV in Ukraine

europemap.jpg

New York State International Training and Research Program Receives $1.5 Million to Conduct HIV Research Training Program in Ukraine

Medicine

Channels:

AIDS, HIV, AIDS research, Hiv Research, Epidemic, Population Health, Hiv Transmission, Disease, Prevention

NIH Funds NYC Center for AIDS Research

Goldstein_Harris_2017_5_56.jpg

The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine, The Rockefeller University, The City University of New York Graduate School of Public Health and Health Policy (CUNY), a $7.5 million grant for the Center for AIDS Research focused on preventing HIV transmission and ending the AIDS epidemic.

Medicine

Channels:

Addressing Adherence: PrEP’s Achilles Heel

Researchers from Penn Medicine have developed a new urine test, called UrSure, to monitor adherence to pre-exposure prophylaxis (PrEP) in order to help curb the HIV epidemic and prevent high-risk populations from being infected with HIV.

Medicine

Channels:

HIVAIDS, Aids Vaccine, Duke Human Vaccine Institute

Investigational Vaccine Protected Monkeys From HIV-Like Virus

Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus.







Chat now!